HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-Frédéric Blanc Selected Research

Paclitaxel (Taxol)

1/2021Triplet combination of durvalumab, tremelimumab, and paclitaxel in biliary tract carcinomas: Safety run-in results of the randomized IMMUNOBIL PRODIGE 57 phase II trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-Frédéric Blanc Research Topics

Disease

41Hepatocellular Carcinoma (Hepatoma)
12/2023 - 06/2002
33Neoplasms (Cancer)
02/2024 - 06/2002
13Adenocarcinoma
10/2023 - 05/2003
10Pancreatic Neoplasms (Pancreatic Cancer)
09/2021 - 10/2014
7Fibrosis (Cirrhosis)
02/2021 - 08/2015
6Liver Neoplasms (Liver Cancer)
02/2023 - 12/2012
5Neoplasm Metastasis (Metastasis)
03/2024 - 06/2002
5Hemorrhage
02/2024 - 08/2009
4Biliary Tract Neoplasms (Biliary Tract Cancer)
05/2024 - 07/2014
4Liver Cell Adenoma (Hepatocellular Adenoma)
02/2024 - 09/2007
3Disease Progression
05/2024 - 07/2014
2Portal Hypertension
10/2023 - 08/2015
2Focal Nodular Hyperplasia
01/2022 - 12/2017
2Carcinoma (Carcinomatosis)
01/2021 - 01/2019
2Diarrhea
01/2020 - 07/2008
2Neutropenia
01/2019 - 07/2014
2Peripheral Nervous System Diseases (PNS Diseases)
01/2019 - 07/2014
2Hypertension (High Blood Pressure)
01/2018 - 10/2013
2Body Weight (Weight, Body)
01/2014 - 01/2007
1Cholangiocarcinoma
03/2024
1Inflammation (Inflammations)
02/2024
1Margins of Excision
11/2023
1Hepatitis B
10/2023
1Acute Intermittent Porphyria (Porphyria, Acute)
10/2022
1Tics (Tic)
01/2022
1Infections
01/2019
1Hand-Foot Syndrome
01/2019
1Esophageal and Gastric Varices (Esophageal Varices)
01/2019

Drug/Important Bio-Agent (IBA)

13Sorafenib (BAY 43-9006)FDA Link
11/2022 - 07/2008
10GemcitabineFDA Link
05/2024 - 07/2014
7Irinotecan (Camptosar)FDA LinkGeneric
01/2021 - 11/2016
7Leucovorin (Folinic Acid)FDA Link
01/2021 - 05/2017
7Fluorouracil (Carac)FDA LinkGeneric
01/2021 - 05/2017
6CateninsIBA
02/2024 - 12/2013
5Proteins (Proteins, Gene)FDA Link
01/2021 - 09/2005
5Matrix Metalloproteinases (MMPs)IBA
01/2007 - 06/2002
4alpha-Fetoproteins (alpha-Fetoprotein)IBA
11/2023 - 05/2017
4Biomarkers (Surrogate Marker)IBA
01/2023 - 12/2013
4Telomerase (Telomerase Reverse Transcriptase)IBA
05/2022 - 10/2015
4beta CateninIBA
01/2020 - 09/2007
4BilirubinIBA
01/2019 - 08/2015
3Bevacizumab (Avastin)FDA Link
10/2023 - 11/2022
3atezolizumabIBA
10/2023 - 11/2022
3CyclinsIBA
01/2022 - 10/2015
3folfirinoxIBA
01/2019 - 12/2015
3Peptide Hydrolases (Proteases)FDA Link
10/2006 - 06/2002
2Immune Checkpoint InhibitorsIBA
05/2024 - 01/2021
2durvalumabIBA
05/2024 - 01/2021
2Cisplatin (Platino)FDA LinkGeneric
05/2024 - 07/2014
2tepotinibIBA
08/2021 - 01/2021
2Pravastatin (Pravachol)FDA LinkGeneric
02/2021 - 01/2007
2PlatinumIBA
01/2021 - 07/2014
2Messenger RNA (mRNA)IBA
01/2020 - 10/2007
2ApolipoproteinsIBA
01/2020 - 09/2005
2cabozantinibIBA
01/2020 - 01/2020
2AlbuminsIBA
01/2020 - 12/2016
2Antiviral Agents (Antivirals)IBA
01/2019 - 11/2018
2Transaminases (Aminotransferases)IBA
01/2019 - 07/2014
2Cyclin A2IBA
12/2018 - 10/2015
2Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2016 - 07/2014
2Adenosine Triphosphatases (ATPase)IBA
12/2012 - 10/2007
2Matrix Metalloproteinase 14 (MT1-MMP)IBA
05/2003 - 06/2002
1spleen fibrinolytic proteinase (human) (SFP)IBA
03/2024
1Triggering Receptor Expressed on Myeloid Cells-1IBA
02/2024
1Glutamine (L-Glutamine)FDA Link
02/2024
1abemaciclibIBA
10/2023
1LY3023414IBA
10/2023
1LY-2157299IBA
10/2023
1tislelizumabIBA
02/2023
1Programmed Cell Death 1 ReceptorIBA
02/2023
1IpilimumabIBA
01/2023
1PorphyrinsIBA
10/2022
1Hydroxymethylbilane Synthase (Porphobilinogen Deaminase)IBA
10/2022
1EnzymesIBA
10/2022
1PorphobilinogenIBA
10/2022
1A-Form DNA (A-DNA)IBA
10/2022
1Heme (Haem)IBA
10/2022
1Contrast MediaIBA
01/2022
1Tyrosine Kinase InhibitorsIBA
12/2021
1N-acetyltalosaminuronic acid (NAT)IBA
09/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1Taxoids (Taxanes)IBA
01/2021
1tremelimumabIBA
01/2021
1Paclitaxel (Taxol)FDA LinkGeneric
01/2021
1Chimeric Antigen ReceptorsIBA
01/2021
1Antisense OligonucleotidesIBA
01/2021
1VaccinesIBA
01/2021
1Immunologic Factors (Immunomodulators)IBA
01/2020
1Apolipoproteins B (ApoB)IBA
01/2020
1regorafenibIBA
01/2020

Therapy/Procedure

14Therapeutics
02/2023 - 07/2008
11Drug Therapy (Chemotherapy)
10/2023 - 05/2012
6Radiofrequency Ablation
03/2024 - 11/2006
4Immunotherapy
02/2024 - 01/2021
3Radiotherapy
12/2023 - 10/2014
3Neoadjuvant Therapy
09/2021 - 10/2014
1Adjuvant Chemotherapy
03/2024
1Critical Care (Surgical Intensive Care)
11/2021
1Drug Tapering
01/2021
1Chemoradiotherapy
01/2019